Rodney James Lane
Research Subjects
Research Interests
Rodney James Lane has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
Michael Appleberg
Department of Vascular Surgery, Royal North Shore Hospital, Sydney, New South Wales, Australia
7 shared publications- Martijn L. Dijkstra
The Department of Surgery, Rijnstate Hospital, Arnhem, The Netherlands; the Division of Vascular Surgery, Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
4 shared publications M. Appleberg
3 shared publicationsMichael Luciano Cuzzilla
Vascular Specialists Investigations and Management, Dalcross Private Hospital, Sydney, New South Wales, Australia
3 shared publicationsNigel Ackroyd
MRCP, FRCS, FRACS; Vascular Research Fellow
3 shared publicationsNyan Y. Khin
Australian School of Advanced Medicine, Macquarie University, Sydney, NSW, Australia
3 shared publications
Latest Publications
- Open Access
- 8 April 2023
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 25 (3) , 981-987
An arterial access system for targeted chemotherapy delivery and arterial-arterial extracorporeal recirculation for ‘end stage’ peripheral vascular disease
Background: Vascular access via a single arterial catheter for targeted chemotherapy delivery has difficulties with concentration, dilution, drug retention, plasma binding, and lack of control of the tumour microcirculation. An implantable arterial access system to accommodate multi-catheter access was developed address these problems. The system was also adapted for isolated arterial-to-arterial extracorporeal suprasystolic perfusion for end stage peripheral vascular disease. The arterial-to-arterial logistics were compared with standard venovenous and arteriovenous fistulae access employed in haemodialysis. Methods: Targeted chemotherapy delivery was addressed in a pilot study of vascular liver isolation. Ten patients with secondary colorectal cancer, were treated with multiple infusions employing up to five individually steered catheters. The arterial-to-arterial extracorporeal access system was also used to treat end stage peripheral vascular disease in 20 patients where amputation was the only option. The trial was named Hypertensive Extracorporeal Limb Perfusion (HELP). Results: Multiple day only infusions produced a partial response or stable disease in six out of the ten patients in an ‘end stage’ setting. The mean survival was 11.2 months. Of the twenty patients facing amputation 40% had avoided amputation at follow-up 22 months and 20% had delay of 4 months. Conclusion: The access system allows repeatable steerable multi-catheter arterial access for chemotherapy delivery to address difficulties of concentration, dilution, plasma binding and microvascular control. The access system supports multiple repeatable suprasystolic extracorporeal arterial to arterial access. It is cardiac independent generating flows of greater than 1 L/min with zero flow in between treatments. The device logistics compares favourably with arteriovenous and venovenous access systems.
- 8 April 2023
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 25 (3) , 981-987
Open AccessAn arterial access system for targeted chemotherapy delivery and arterial-arterial extracorporeal recirculation for ‘end stage’ peripheral vascular disease
Background: Vascular access via a single arterial catheter for targeted chemotherapy delivery has difficulties with concentration, dilution, drug retention, plasma binding, and lack of control of the tumour microcirculation. An implantable arterial access system to accommodate multi-catheter access was developed address these problems. The system was also adapted for isolated arterial-to-arterial extracorporeal suprasystolic perfusion for end stage peripheral vascular disease. The arterial-to-arterial logistics were compared with standard venovenous and arteriovenous fistulae access employed in haemodialysis. Methods: Targeted chemotherapy delivery was addressed in a pilot study of vascular liver isolation. Ten patients with secondary colorectal cancer, were treated with multiple infusions employing up to five individually steered catheters. The arterial-to-arterial extracorporeal access system was also used to treat end stage peripheral vascular disease in 20 patients where amputation was the only option. The trial was named Hypertensive Extracorporeal Limb Perfusion (HELP). Results: Multiple day only infusions produced a partial response or stable disease in six out of the ten patients in an ‘end stage’ setting. The mean survival was 11.2 months. Of the twenty patients facing amputation 40% had avoided amputation at follow-up 22 months and 20% had delay of 4 months. Conclusion: The access system allows repeatable steerable multi-catheter arterial access for chemotherapy delivery to address difficulties of concentration, dilution, plasma binding and microvascular control. The access system supports multiple repeatable suprasystolic extracorporeal arterial to arterial access. It is cardiac independent generating flows of greater than 1 L/min with zero flow in between treatments. The device logistics compares favourably with arteriovenous and venovenous access systems.
- Open Access
- 1 December 2018
- Published by Elsevier in Journal of Controlled Release
- Vol. 292, 18-28
The integration of pharmacology and pathophysiology into locoregional chemotherapy delivery via mass fluid transfer
- 1 December 2018
- Published by Elsevier in Journal of Controlled Release
- Vol. 292, 18-28
Open AccessThe integration of pharmacology and pathophysiology into locoregional chemotherapy delivery via mass fluid transfer
- Open Access
- 7 March 2018
- Published by Taylor & Francis in Future Oncology
- Vol. 14 (7) , 647-663
Challenges in Chemotherapy Delivery: Comparison of Standard Chemotherapy Delivery to Locoregional Vascular Mass Fluid Transfer
Standard intravenous chemotherapy delivery to neoplasms relies on simple diffusion gradients from the intravascular to the interstitial space. Systemic perfusion creates untoward effects on normal tissue limiting both concentration and exposure times. Regional intra-arterial therapy is limited by drug recirculation and vascular isolation repeatability and does not address the interstitial microenvironment. Barriers to delivery relate to chaotic vascular architecture, heterogeneous fluid flux, increased interstitial and variable solid tumor pressure and ischemia. To address these difficulties, a delivery system was developed allowing mass fluid transfer of chemotherapeutic agents into the interstitium. This implantable, reusable system is comprised of multiple independently steerable balloons and catheters capable of controlling the locoregional hydraulic and oncotic forces across the vascular endothelium.
- 7 March 2018
- Published by Taylor & Francis in Future Oncology
- Vol. 14 (7) , 647-663
Open AccessChallenges in Chemotherapy Delivery: Comparison of Standard Chemotherapy Delivery to Locoregional Vascular Mass Fluid Transfer
Standard intravenous chemotherapy delivery to neoplasms relies on simple diffusion gradients from the intravascular to the interstitial space. Systemic perfusion creates untoward effects on normal tissue limiting both concentration and exposure times. Regional intra-arterial therapy is limited by drug recirculation and vascular isolation repeatability and does not address the interstitial microenvironment. Barriers to delivery relate to chaotic vascular architecture, heterogeneous fluid flux, increased interstitial and variable solid tumor pressure and ischemia. To address these difficulties, a delivery system was developed allowing mass fluid transfer of chemotherapeutic agents into the interstitium. This implantable, reusable system is comprised of multiple independently steerable balloons and catheters capable of controlling the locoregional hydraulic and oncotic forces across the vascular endothelium.
- 25 March 2016
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 23 (11) , 3699-3708
Safety and Feasibility of Repeatable Hepatic Vascular Isolation Chemotherapy: A Pilot Study
The authors herein describe a novel method of repeatable hepatic isolation using an implantable access system allowing simultaneous control of hepatic arterial and portal flows by multiple endovascular catheters. The aim of this study was to assess the feasibility and safety of the system and to compress standard intravenous chemotherapy into 4 weeks of targeted intra-arterial delivery. An arterial access system was implanted to the axillary artery via an anastomosis. Infusions of oxaliplatin were performed biweekly for 4 weeks, using balloon catheters to achieve hepatic isolation and segmental selectivity for 20-25 min. Fifty-seven treatments under general anesthetic were performed in ten patients with inoperable chemotherapy-refractory metastatic colorectal cancer. Systemic, intrahepatic, and hepatic venous pressures were recorded to assess vascular isolation, and platinum levels were measured to assess chemotherapy distribution. Pressure verified, multiple day-only hepatic vascular isolation infusions were achieved in nine of ten patients, with a single patient receiving multiple hepatic arterial infusions. Positron emission tomography-computed tomography (PET-CT) imaging confirmed partial response in three of ten patients and stable disease in three of ten patients. Systemic toxicity was minimal as all treatment-related gastrointestinal and neuropathic symptoms reported throughout the 4 weeks were grades 1-2. Intra-arterial chemotherapy infusions with hepatic vascular isolation can be achieved repeatedly with targeted selectivity and minimal complications using an implantable multicatheter access system. Oxaliplatin infusions over a 4-week period may achieve tumor response in selected patients in the salvage setting. The technique should be further assessed in a phase Ib/II study.
- 25 March 2016
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 23 (11) , 3699-3708
Safety and Feasibility of Repeatable Hepatic Vascular Isolation Chemotherapy: A Pilot Study
The authors herein describe a novel method of repeatable hepatic isolation using an implantable access system allowing simultaneous control of hepatic arterial and portal flows by multiple endovascular catheters. The aim of this study was to assess the feasibility and safety of the system and to compress standard intravenous chemotherapy into 4 weeks of targeted intra-arterial delivery. An arterial access system was implanted to the axillary artery via an anastomosis. Infusions of oxaliplatin were performed biweekly for 4 weeks, using balloon catheters to achieve hepatic isolation and segmental selectivity for 20-25 min. Fifty-seven treatments under general anesthetic were performed in ten patients with inoperable chemotherapy-refractory metastatic colorectal cancer. Systemic, intrahepatic, and hepatic venous pressures were recorded to assess vascular isolation, and platinum levels were measured to assess chemotherapy distribution. Pressure verified, multiple day-only hepatic vascular isolation infusions were achieved in nine of ten patients, with a single patient receiving multiple hepatic arterial infusions. Positron emission tomography-computed tomography (PET-CT) imaging confirmed partial response in three of ten patients and stable disease in three of ten patients. Systemic toxicity was minimal as all treatment-related gastrointestinal and neuropathic symptoms reported throughout the 4 weeks were grades 1-2. Intra-arterial chemotherapy infusions with hepatic vascular isolation can be achieved repeatedly with targeted selectivity and minimal complications using an implantable multicatheter access system. Oxaliplatin infusions over a 4-week period may achieve tumor response in selected patients in the salvage setting. The technique should be further assessed in a phase Ib/II study.
- Open Access
- 11 March 2014
- Published by SAGE Publications in Obstetric Medicine
- Vol. 7 (2) , 84-89
The effect of pregnancy on venous valve repair to the sapheno-femoral junction for varicose veins
Objectives: Pregnancy represents a special situation where both the mechanical and hormonal instigating factors of varicose veins are reversible with the venous valve cusps preserved. Exostent venous valve repairs are a physiological alternative which minimises stimulus to collateral growth (recurrence). The study purpose was to assess the effect of pregnancy on the durability of valve repairs. Methods: In a prospective study of 36 limbs, 20 young females (30 ± 4.7 years) had an exostent implanted to the terminal valve of the saphenofemoral junction for varicose veins. At routine long-term follow up (9.7 ± 3.8 years), 38 pregnancies were completed (mean: 1.8, range: 1–4). The controls were a non-pregnant group of limbs ( n = 386). Results: At 9.7 years, the internal diameter of the greater saphenous vein (GSV) changed from 7.8 ± 2.8 mm preoperatively to 4.5 ± 1.4 mm post-operatively. Recurrence was associated with reflux, preoperative deep system and ovarian vein involvement. Pregnancy induced 33.3% recurrences compared with non-pregnant controls (4.7%) similarly treated or 22.8% compared with non-pregnant ablative controls. At 9.7 years, symptomatic improvement continued with significantly better CEAP status (described later) (31C S EAP preoperative to 6C S EAP) with no further truncal ablation (strip, laser) required. Conclusions: Venous valve repairs can withstand the special stresses of pregnancy. There is no need to ablate the GSV. This approach is contrary to the traditional dictum; the treatment of varicose veins should be delayed until the family is completed.
- 11 March 2014
- Published by SAGE Publications in Obstetric Medicine
- Vol. 7 (2) , 84-89
Open AccessThe effect of pregnancy on venous valve repair to the sapheno-femoral junction for varicose veins
Objectives: Pregnancy represents a special situation where both the mechanical and hormonal instigating factors of varicose veins are reversible with the venous valve cusps preserved. Exostent venous valve repairs are a physiological alternative which minimises stimulus to collateral growth (recurrence). The study purpose was to assess the effect of pregnancy on the durability of valve repairs. Methods: In a prospective study of 36 limbs, 20 young females (30 ± 4.7 years) had an exostent implanted to the terminal valve of the saphenofemoral junction for varicose veins. At routine long-term follow up (9.7 ± 3.8 years), 38 pregnancies were completed (mean: 1.8, range: 1–4). The controls were a non-pregnant group of limbs ( n = 386). Results: At 9.7 years, the internal diameter of the greater saphenous vein (GSV) changed from 7.8 ± 2.8 mm preoperatively to 4.5 ± 1.4 mm post-operatively. Recurrence was associated with reflux, preoperative deep system and ovarian vein involvement. Pregnancy induced 33.3% recurrences compared with non-pregnant controls (4.7%) similarly treated or 22.8% compared with non-pregnant ablative controls. At 9.7 years, symptomatic improvement continued with significantly better CEAP status (described later) (31C S EAP preoperative to 6C S EAP) with no further truncal ablation (strip, laser) required. Conclusions: Venous valve repairs can withstand the special stresses of pregnancy. There is no need to ablate the GSV. This approach is contrary to the traditional dictum; the treatment of varicose veins should be delayed until the family is completed.
- 1 November 2013
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 58 (5) , 1244-1253
Hypertensive extracorporeal limb perfusion for critical limb ischemia
- 1 November 2013
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 58 (5) , 1244-1253
Hypertensive extracorporeal limb perfusion for critical limb ischemia
- 1 September 2013
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 46 (3) , 360-365
Endovenous Valve Transfer for Chronic Deep Venous Insufficiency
- 1 September 2013
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 46 (3) , 360-365
Endovenous Valve Transfer for Chronic Deep Venous Insufficiency
- 1 April 2013
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 1 (2) , 181-186
Popliteal vein compression syndrome pathophysiology and correlation with popliteal compartment pressures
- 1 April 2013
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 1 (2) , 181-186
Popliteal vein compression syndrome pathophysiology and correlation with popliteal compartment pressures
- 1 June 2012
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 55 (6) , 53S-54S
PS104. Hypertensive Extracorporeal Limb Perfusion (HELP)
- 1 June 2012
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 55 (6) , 53S-54S
PS104. Hypertensive Extracorporeal Limb Perfusion (HELP)
- 1 June 2012
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 55 (6) , 61S
PS134. Endovenous Valve Transfer for Chronic Venous Hypertension
- 1 June 2012
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 55 (6) , 61S
PS134. Endovenous Valve Transfer for Chronic Venous Hypertension